Advertisement Pharmaceutical Business review - Page 494 of 5254 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
December 18, 2025

Alnylam plans $250m investment in Norton manufacturing facility, US

Alnylam Pharmaceuticals is set to invest $250m in the expansion of its facility in Norton, Massachusetts, US, to meet the growing global demand for RNA interference (RNAi) therapeutics.

Continue
The facility expansion is said to enable support for future medicine launches from Alnylam’s development pipeline. Credit: Bo Shen / Shutterstock.com.
December 18, 2025

EC approves Incyte’s Minjuvi combo for follicular lymphoma

Incyte licenses exclusive global development and commercialisation rights to tafasitamab from Xencor. Credit: Piotr Swat/Shutterstock.com.
December 17, 2025

Harbour BioMed and BMS sign multi-specific antibody collab

Harbour BioMed will work alongside BMS to progress and expedite the programmes aimed at the discovery of multi-specific antibodies. Credit: shisu_ka/Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. INCOG reveals $200m injectable drug expansion in Indiana
  2. LEO Pharma applies to EMA to expand Anzupgo use to adolescents
  3. SK Capital Partners supports Swixx BioPharma’s global expansion
  4. FDA approves Acadia’s Daybue Stix for Rett syndrome
  5. Sobi buys Arthrosi to expand gout treatment pipeline

PRESS RELEASES

SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Pharmaceutical Business Review
Christian Mias to Succeed Andreas Reisse as CEO of SCHOTT Pharma
Pharmaceutical Business Review
LTS completes acquisition of Renaissance Lakewood, expanding global CDMO capabilities

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography